Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MR Imaging of Lung in the Follow-up Assessment of Cystic Fibrosis

NCT: NCT03357562 · TERMINATED

NCT IDNCT03357562
StatusTERMINATED
Start Date2018-05-05
Completion2025-03-06
SponsorUniversity Hospital, Bordeaux (OTHER)
First posted
Last updated

Brief Summary

The aim of the study is to assess the diagnostic sensitivity of MRI to detect changes in Helbich-Bhalla scoring over time in patients with cystic fibrosis

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑